Photocure renegotiates HexVix licence: GE out, Ipsen in
This article was originally published in Clinica
Executive Summary
Photocure has put together a new commercial strategy for HexVix (hexaminolevulinate hydrochloride), its flagship product which helps in the diagnosis and resection of bladder cancer.